RHUMBLINE ADVISERS - PROGENIC PHARMACEUTICALS INC C ownership

PROGENIC PHARMACEUTICALS INC C's ticker is and the CUSIP is 516CVR103. A total of 1 filers reported holding PROGENIC PHARMACEUTICALS INC C in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of PROGENIC PHARMACEUTICALS INC C
ValueSharesWeighting
Q1 2023$0216,5260.0%0.00%
Q4 2022$0216,5260.0%0.00%
Q3 2022$0216,5260.0%0.00%
Q2 2022$0216,5260.0%0.00%
Q1 2022$0216,526
-0.3%
0.00%
Q4 2021$0217,1380.0%0.00%
Q3 2021$0217,1380.0%0.00%
Q2 2021$0217,138
-2.0%
0.00%
Q1 2021$0221,618
+5.8%
0.00%
Q4 2020$0209,5180.0%0.00%
Q3 2020$0209,518
-5.5%
0.00%
Q2 2020$0221,6180.00%
Other shareholders
PROGENIC PHARMACEUTICALS INC C shareholders Q3 2020
NameSharesValueWeighting ↓
RHUMBLINE ADVISERS 209,518$00.00%
View complete list of PROGENIC PHARMACEUTICALS INC C shareholders